`

Shuimu BioSciences

Biotechnology Research

Specialities :
Drug discovery
Cryo-em
Microed
Drugdevelopment
Proteinstructure

+10

revenue-icon Revenue
11M - 100M
funding-icon Total Funding
$3.93M
size-icon Size
11 - 50

Frequently Asked Questions About Shuimu BioSciences

What does Shuimu biosciences do?+

Shuimu is a rapidly evolving global cryo-EM & AI platform for early drug discovery, founded in 2017 and headquartered in Beijing, China. Shuimu drives innovation to accelerate the development of innovative drugs. Shuimu leverages the power of cutting-edge cryo-EM & AI technology to help its partners gain key structural insights into the target proteins and complexes. The team consists of top talents with global backgrounds in the field of structural biology, machine learning, protein science, and drug chemistry. Learn more about Shuimu and check out its cryo-EM precision imaging platform by visiting shuimubio.com or sending an email to hi@shuimubio.com

What are Shuimu biosciences's specialties? +

Drug discovery,cryo-em,microed,drugdevelopment,proteinstructure,biophysics,antibodies,virology,nanoparticles,aav,structuralbiology,cro,ppi,exosomes,and liposomes

What is Shuimu biosciences's industry? +

Shuimu biosciences operates in the Biotechnology research industry.

What is Shuimu biosciences's revenue? +

Shuimu biosciences's revenue is 11m - 100m

What is Shuimu biosciences's company size? +

Shuimu biosciences has 11 - 50 employees.

The Go-to Sales Technology According to G2

G2 Badges Map
Get Started With Clodura
Sign Up

Sign Up for Free

Get Started with the Free Forever plan! No credit card needed. Enjoy up to 10,000 free email credits per month at no cost.

Supercharge Your Prospecting

Supercharge Your Prospecting

Start Prospecting from Clodura.AI's database of 600M+ verified B2B contacts and 120M+ direct dials along with 18M+ companies' org charts.

Grow Your Business

Grow Your Business

Unlock the prospect's contact details, including verified email, direct dials, add them to cadence, and close more deals.